SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Apimeds Pharmaceuticals US, Inc APUS AMEX

American Stock Excha • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Apimeds Pharmaceuticals US, Inc (APUS) 有 10 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ANTX, IGC, MIRA, MLSS, MYO, NXTC 等.

APUS 的市值为 $2.36M, 而同行平均市值为 $42.59M. APUS 显著小于其平均同行.

同行与相似公司 — APUS

AN2 Therapeutics, Inc.

$3.26 +9.40% $89.33M

IGC Pharma, Inc.

$0.32 +3.19% $31.61M

MIRA Pharmaceuticals, Inc.

$1.03 -1.90% $43.28M

Milestone Scientific Inc.

$0.28 -4.32% $22.48M

$0.80 +1.01% $30.81M

$12.02 -5.87% $32.21M

Precision Optics Corporation, Inc.

$4.48 +3.94% $34.64M

$6.09 +3.57% $74.9M

$1.11 +8.82% $49.58M

$0.83 -1.87% $17.05M

其他人也在看

AN2 Therapeutics, Inc.

MIRA Pharmaceuticals, Inc.

Precision Optics Corporation, Inc.

IGC Pharma, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言